Cargando…

Metabolic Surgery for Type 2 Diabetes with BMI <35 kg/m(2): An Endocrinologist’s Perspective

Is bariatric surgery as primary therapy for type 2 diabetes mellitus (T2DM) with body mass index (BMI) <35 kg/m(2) justified? Open-label studies have shown that bariatric surgery causes remission of diabetes in some patients with BMI <35 kg/m(2). All such patients treated had substantial weigh...

Descripción completa

Detalles Bibliográficos
Autor principal:	Lebovitz, Harold E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3653036/ https://www.ncbi.nlm.nih.gov/pubmed/23515973 http://dx.doi.org/10.1007/s11695-013-0907-1

Ejemplares similares

Review of Metabolic Surgery for Type 2 Diabetes in Patients with a BMI < 35 kg/m(2)
por: Shimizu, Hideharu, et al.
Publicado: (2012)

Metabolic bariatric surgery and type 2 diabetes mellitus: an endocrinologist's perspective
por: Ganguly, Sonali, et al.
Publicado: (2015)

Transcutaneous carbon dioxide measurements in anesthetized apneic patients with BMI > 35 kg/m(2)
por: Eley, Victoria A., et al.
Publicado: (2023)

Bariatric Surgery for Type 2 Diabetes Mellitus in Patients with BMI <30 kg/m(2): A Systematic Review and Meta-Analysis
por: Baskota, Attit, et al.
Publicado: (2015)

Combined Approach: FFQ, DII, Anthropometric, Biochemical and DNA Damage Parameters in Obese with BMI ≥ 35 kg m(−2)
por: Milić, Mirta, et al.
Publicado: (2023)

COVID 19 and diabetes: An endocrinologist's perspective
por: Behera, Kishore K., et al.
Publicado: (2020)

Pediatric Endocrinologists' Management of Children With Type 2 Diabetes
por: Wong, Kam, et al.
Publicado: (2010)

Binational cohort study comparing the management and outcomes of pregnant women with a BMI >50–59.9 kg/m(2) and those with a BMI ≥60 kg/m(2)
por: McCall, Stephen J, et al.
Publicado: (2018)

Long-term evaluation of patients with BMI = 50kg/m(2) who underwent Bariatric Surgery
por: MEIRA, MATHEUS DUARTE, et al.
Publicado: (2023)

A systematic review of UK‐based long‐term nonsurgical interventions for people with severe obesity (BMI ≥35 kg m(−2))
por: Aceves‐Martins, M., et al.
Publicado: (2020)

Response to Should sleeve gastrectomy be a preoperative standard in kidney transplant waitlisted patients with a BMI of 35 kg/m(2)
por: Dziodzio, Tomasz, et al.
Publicado: (2022)

Clinical Challenge: Patient With Severe Obesity BMI 46 kg/m(2)
por: Srivastava, Gitanjali, et al.
Publicado: (2019)

TyG Index Performs Better Than HOMA-IR in Chinese Type 2 Diabetes Mellitus with a BMI < 35 kg/m(2): A Hyperglycemic Clamp Validated Study
por: Luo, Ping, et al.
Publicado: (2022)

OAGB with shortened excluded ileal loop as an effective treatment for type 2 diabetes mellitus in the cases of Caucasian men and women with obesity of the first degree (BMI 30–35 kg/m(2))
por: Jaworski, Paweł, et al.
Publicado: (2023)

Laparoscopic Sleeve Gastrectomy is a Safe and Effective Bariatric Procedure for the Lower BMI (35.0–43.0 kg/m(2)) Population
por: Gluck, Brian, et al.
Publicado: (2010)

National Differences in Remission of Type 2 Diabetes Mellitus After Roux-en-Y Gastric Bypass Surgery-Subgroup Analysis of 2-Year Results of the Diabetes Surgery Study Comparing Taiwanese with Americans with Mild Obesity (BMI 30–35 kg/m(2))
por: Chong, Keong, et al.
Publicado: (2016)

Effects of Laparoscopic Roux-en-Y Gastric Bypass for Type 2 Diabetes Mellitus: Comparison of BMI > 30 and < 30 kg/m(2)
por: Ke, Zhigang, et al.
Publicado: (2017)

Better Outcomes in Severe and Morbid Obese Patients (BMI > 35 kg/m(2)) in Primary Endo-Model Rotating-Hinge Total Knee Arthroplasty
por: Lozano, Luis M., et al.
Publicado: (2012)

Changes in Adipokines following Laparoscopic Roux-en-Y Gastric Bypass Surgery in Chinese Individuals with Type 2 Diabetes Mellitus and BMI of 22–30 kg·m(−2)
por: Shrestha, Chandrama, et al.
Publicado: (2013)

Dynamics of type 2 diabetes mellitus laboratory remission after Roux-en-Y gastric bypass in patients with body mass index lower than 35 kg/m(2) and higher than 35 kg/m(2) in a 3-year observation period
por: Kaska, Łukasz, et al.
Publicado: (2014)

The effect of morbid obesity (BMI ≥ 35 kg/m(2)) on functional outcome and complication rate following unicompartmental knee arthroplasty: a case-control study
por: Polat, Ayşe Esin, et al.
Publicado: (2019)

EMBIO trial study protocol: left gastric artery embolisation for weight loss in patients living with obesity with a BMI 35–50 kg/m(2)
por: Patel, Prashant, et al.
Publicado: (2023)

Case Report: Off Label Utilization of Topiramate and Metformin in Patients With BMI ≥50 kg/m(2) Prior to Bariatric Surgery
por: Sari, Cetin, et al.
Publicado: (2021)

One anastomosis gastric bypass surgery in Type2 diabetes patients with body mass index < 35 kg/m(2): A multi-center retrospective cohort study
por: Amirbeigi, Alireza, et al.
Publicado: (2022)

Disability Affects the 6-Minute Walking Distance in Obese Subjects (BMI>40 kg/m(2))
por: Donini, Lorenzo Maria, et al.
Publicado: (2013)

Roux-en-Y gastric bypass for Chinese type 2 diabetes mellitus patients with a BMI < 28 kg/m(2): a multi-institutional study
por: Liang, Hui, et al.
Publicado: (2015)

SAT-LB025 Analysis of Benefit/Risk in the Subgroup of Patients with BMI of >=27 Kg/m(2) in the Dapagliflozin DEPICT-1 and -2 Trials in Type 1 Diabetes
por: Mathieu, Chantal, et al.
Publicado: (2019)

Insulin: Potential Negative Consequences of Early Routine Use in Patients With Type 2 Diabetes
por: Lebovitz, Harold E.
Publicado: (2011)

Rising prevalence of BMI ≥40 kg/m(2): A high‐demand epidemic needing better documentation
por: Williamson, Kath, et al.
Publicado: (2020)

Neuropsychiatric and metabolic aspects of dopaminergic therapy: perspectives from an endocrinologist and a psychiatrist
por: Athanasoulia-Kaspar, Anastasia P, et al.
Publicado: (2018)

A Randomized Comparison of Non-Channeled Glidescope(TM) Titanium Versus Channeled KingVision(TM) Videolaryngoscope for Orotracheal Intubation in Obese Patients with BMI > 35 kg·m(−2)
por: Brozek, Tomas, et al.
Publicado: (2020)

The effect of long Roux-en-Y gastrojejunostomy in gastric cancer patients with type 2 diabetes and body mass index < 35 kg/m(2): preliminary results
por: Kim, Ji Won, et al.
Publicado: (2015)

TOR-centric view on insulin resistance and diabetic complications: perspective for endocrinologists and gerontologists
por: Blagosklonny, M V
Publicado: (2013)

CMR stress testing in a patient with morbid obesity (BMI 58 kg/m(2)) and suspected coronary artery disease
por: Stoiber, Lukas, et al.
Publicado: (2018)

Associations between anthropometric parameters and lipid profiles in Chinese individuals with age ≥40 years and BMI <28kg/m(2)
por: Yang, Zhi, et al.
Publicado: (2017)

Modified three-level techniques of retroperitoneal laparoscopic procedures to treat adrenal lesions for patients with BMI ≥ 25 Kg/m(2)
por: Hu, Minxiong, et al.
Publicado: (2020)

One anastomosis gastric bypass as a one-stage bariatric surgical procedure in patients with BMI ≥ 50 kg/m(2)
por: Kermansaravi, Mohammad, et al.
Publicado: (2022)

The Effects of Laparoscopic Sleeve Gastrectomy on Glucose Metabolism in Patients with a Body Mass Index below 35 kg/m²
por: Batman, Burçin, et al.
Publicado: (2020)

Consensus Statements from the Diabetologists & Endocrinologists Alliance for the Management of People with Hypertension and Type 2 Diabetes Mellitus
por: Tong, Peter Chun-Yip, et al.
Publicado: (2023)

Baseline of visceral fat area and decreased body weight correlate with improved pulmonary function after Roux-en-Y Gastric Bypass in Chinese obese patients with BMI 28–35 kg/m(2) and Type 2 diabetes: a 6-month follow-up
por: Tu, Yinfang, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_eaktt3vev8m6ojars4rt9mbs7j